Praxbind (Boehringer Ingelheim Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Praxbind drug offered from Boehringer Ingelheim Pharmaceuticals, Inc.. This Humanized Monoclonal Antibody Fragment [EPC],Antibodies, Monoclonal, Humanized [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Boehringer Ingelheim Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | idarucizumab |
| SUBSTANCE NAME: | IDARUCIZUMAB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Humanized Monoclonal Antibody Fragment [EPC],Antibodies, Monoclonal, Humanized [Chemical/Ingredient] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2015-10-21 |
| END MARKETING DATE: | 0000-00-00 |
Praxbind HUMAN PRESCRIPTION DRUG Details:
| Item Description | Praxbind from Boehringer Ingelheim Pharmaceuticals, Inc. |
| LABELER NAME: | Boehringer Ingelheim Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/mL) |
| START MARKETING DATE: | 2015-10-21 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0597-0197_979be189-6765-fb1a-e1a2-933fd93c3c3b |
| PRODUCT NDC: | 0597-0197 |
| APPLICATION NUMBER: | BLA761025 |
Other IDARUCIZUMAB Pharmaceutical Manufacturers / Labelers:
